5:40 PM ET
Earnings Call
▶ Call
Cumberland Pharmaceuticals Earnings Call: Key Takeaways
Cumberland transformed into an innovation-focused biopharma after selling its commercial portfolio for $100 million, shifting focus to its late-stage clinical pipeline led by Ifetroban.
- Call
- Nov 10, 2026, 4:30 PM ET